Transgene Biotek Ltd.
| BSE: 526139 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE773D01018 |
| BSE 00:00 | 29 Sep | 4.16 |
-0.10 (-2.35%) |
OPEN
4.06 |
HIGH
4.30 |
LOW
4.05 |
| NSE 05:30 | 01 Jan | Transgene Biotek Ltd |
| OPEN | 4.06 |
| PREVIOUS CLOSE | 4.26 |
| VOLUME | 21876 |
| 52-Week high | |
| 52-Week low | |
| P/E | |
| Mkt Cap.(Rs cr) | 32 |
| Buy Price | 4.10 |
| Buy Qty | 50.00 |
| Sell Price | 4.28 |
| Sell Qty | 4290.00 |
Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 505.60 | -0.90 | N.A. | N.A. | 121308.60 |
| Dr Reddy's Labs | 5083.50 | -0.85 | 5514.65 | 2497.60 | 84518.27 |
| Divi's Lab. | 3057.30 | -1.15 | N.A. | N.A. | 81156.03 |
| Cipla | 762.25 | -1.60 | 819.00 | 356.75 | 61464.03 |
| Biocon | 455.85 | 1.21 | N.A. | N.A. | 54702.00 |
| Aurobindo Pharma | 796.55 | -0.63 | N.A. | N.A. | 46669.86 |
| Torrent Pharma. | 2712.70 | 0.74 | N.A. | N.A. | 45904.31 |
| Lupin | 998.00 | -0.98 | N.A. | N.A. | 45234.35 |
| Cadila Health. | 387.55 | -0.76 | N.A. | N.A. | 39673.49 |
| Abbott India | 16398.10 | 0.47 | 18569.00 | 10350.00 | 34845.96 |
| Alkem Lab | 2779.40 | 0.27 | N.A. | N.A. | 33227.73 |
| Apollo Hospitals | 2085.15 | 1.22 | 2112.95 | 1047.45 | 29008.61 |
| Piramal Enterp. | 1253.15 | -2.40 | 1829.47 | 608.00 | 28264.80 |
| Ipca Labs. | 2132.30 | 2.66 | N.A. | N.A. | 26941.61 |
| Glaxosmi. Pharma | 1572.65 | -0.27 | 1805.00 | 1046.40 | 26642.26 |
| Pfizer | 4945.60 | -1.36 | 5230.00 | 3069.40 | 22626.12 |
| Syngene Intl. | 564.50 | -4.01 | N.A. | N.A. | 22580.00 |
| Sanofi India | 8473.60 | 0.00 | 8999.00 | 5684.95 | 19514.70 |
| Alembic Pharma | 949.90 | -3.60 | N.A. | N.A. | 18670.29 |
| Natco Pharma | 953.40 | 1.58 | N.A. | N.A. | 17370.95 |
Quick Links for Transgene Biotek:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
